AXONE PHARMA
0830.551.216 · rovalta.com · 08/11/2026
AXONE PHARMA
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOAXONE PHARMA is a Public limited company incorporated in 2010. Its main activity is: Agents specialised in the sale of other particular products. Its registered office is in Braine-l'Alleud. It employs on average 28,2 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0830.551.216
- Incorporation
- 22/10/2010
- Legal form
- Public limited company
- Registered office
- Boulevard de France 9 box A
1420 Braine-l'Alleud · WallonieSee on map - Contributed capital
- 300 000,00 €
- Latest accounts
- 31/12/2025
- Average workforce
- 28,2 ETP
Joint committees (2)
- 200
- 218
Financials
Source · NBB, 15 filingsTrend over 12 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Revenue | 27,1 M € | +86.2% | 14,5 M € | +4.3% | 13,9 M € | +0.9% | 13,8 M € | -39.2% | 22,7 M € |
| EBITDA | 2,4 M € | +150% | 973,8 k € | +50.7% | 646,2 k € | -47.9% | 1,2 M € | -65.9% | 3,6 M € |
| Operating result | 2,2 M € | +139% | 938,6 k € | +49.0% | 629,8 k € | -31.0% | 913,1 k € | -71.6% | 3,2 M € |
| Net result | 1,6 M € | +132% | 695,9 k € | +24.9% | 557,2 k € | -18.3% | 682,2 k € | -72.5% | 2,5 M € |
| Balance sheet | |||||||||
| Equity | 8,1 M € | +24.9% | 6,5 M € | +12.1% | 5,8 M € | -33.8% | 8,7 M € | +8.5% | 8 M € |
| Total assets | 16,2 M € | +76.4% | 9,2 M € | +6.2% | 8,7 M € | -14.3% | 10,1 M € | -21.3% | 12,9 M € |
| Cash | 2,7 M € | +132% | 1,2 M € | +296% | 300 k € | -11.0% | 337,3 k € | – | |
| Debts | 7,6 M € | +209% | 2,4 M € | -11.7% | 2,8 M € | +135% | 1,2 M € | -74.9% | 4,7 M € |
| Other | |||||||||
| Workforce | 28,2 ETP | +0.4% | 28,1 ETP | -6.6% | 30,1 ETP | -1.3% | 30,5 ETP | -1.3% | 30,9 ETP |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20253 active · 6 ended
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
| MandateDirector01/12/2020 → 2020 accountsendedManaging director2021 accountsended | |||
| DirectorManaging director21/02/2011 → 2011 accountsendedMandate2012 accountsended | |||
| Managing director |
Ended mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Ruben Suply | Director01/12/2020 → 2020 accounts | ||
Eric Van Nueten | Managing director21/02/2011 → 2011 accounts | ||
Frank Coene | Managing director21/02/2011 → 2011 accounts | ||
Olivier Delaere | Managing director22/10/2010 → 21/02/2011 |
Other companies at this address
Boulevard de France 9 1420 Braine-l'Alleud| Company | CBE no. |
|---|---|
ABL TRADING● Active | 1017.220.984 |
ABService International● Active | 0727.578.192 |
ACS IMMOBILIERE● Liquidation | 0643.609.648 |
ALLIANCE TAXI● Active | 0659.905.450 |
ALSY BELGIUM● Active | 0776.913.679 |
Alsy Consulting● Active | 1030.866.609 |
AQUA-FLO● Active | 0668.793.224 |
ARTISAN WINE EXPORTS● Active | 0628.960.866 |
AUXILIUM GROUP● Active | 0691.872.789 |
AZ TAXI PROXI● Active | 0747.739.346 |
BELGA TOITURE● Active | 0838.031.302 |
BLUX DISTRIBUTION● Active | 1040.946.986 |
BONFITTO NEWCO● Active | 0838.049.316 |
BOX ITTRE● Active | 1032.497.791 |
CASA A++● Active | 1016.026.795 |
Céline SAEZ ALVAREZ● Active | 1024.885.766 |
Conva Tec Belgium● Active | 0881.716.241 |
DCM SYSTEMATIC SERVICES● Active | 0800.997.987 |
DIESELMOT● Active | 0452.104.132 |
DIPLOMACY AND GLOBAL RISK● Active | 0870.535.804 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Full model | Full model | Full model | Full model | Full model | Full model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 05/06/2026 | 26/06/2025 | 08/07/2024 | 28/06/2023 | 30/06/2022 | 16/06/2021 |
| General meeting | 11/05/2026 | 12/05/2025 | 13/05/2024 | 15/05/2023 | 19/05/2022 | 20/05/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 15 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Full model | 31/12/2025 | 11/05/2026 | 05/06/2026 | French | |
| Full model | 31/12/2024 | 12/05/2025 | 26/06/2025 | French | |
| Full model | 31/12/2023 | 13/05/2024 | 08/07/2024 | French | |
| Full model | 31/12/2022 | 15/05/2023 | 28/06/2023 | French | |
| Full model | 31/12/2021 | 19/05/2022 | 30/06/2022 | French | |
| Full model | 31/12/2020 | 20/05/2021 | 16/06/2021 | French | |
| Full model | 31/12/2019 | 21/05/2020 | 27/05/2020 | French | |
| Full model | 31/12/2018 | 16/05/2019 | 11/09/2019 | French | |
| Full model | 31/12/2017 | 17/05/2018 | 16/07/2018 | French | |
| Full model | 31/12/2016 | 16/03/2017 | 29/06/2017 | French | |
| Full model | 31/12/2015 | 17/03/2016 | 19/08/2016 | French | |
| Full model | 31/12/2014 | 19/03/2015 | 16/06/2015 | French | |
| Full model | 31/12/2013 | 20/03/2014 | 22/07/2014 | French | |
| Full model | 31/12/2012 | 21/03/2013 | 17/07/2013 | French | |
| Full model | 31/12/2011 | 15/03/2012 | 23/08/2012 | French |
Valuation
Indicative valuation
As an indication, this company is worth
between 10 M€ and 25 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20253 active · 6 ended
Active mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
| MandateDirector01/12/2020 → 2020 accountsendedManaging director2021 accountsended | |||
| DirectorManaging director21/02/2011 → 2011 accountsendedMandate2012 accountsended | |||
| Managing director |
Ended mandates
| Director | Mandates in this company | Period | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
Ruben Suply | Director01/12/2020 → 2020 accounts | ||
Eric Van Nueten | Managing director21/02/2011 → 2011 accounts | ||
Frank Coene | Managing director21/02/2011 → 2011 accounts | ||
Olivier Delaere | Managing director22/10/2010 → 21/02/2011 |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Mandates05/08/2026Démission et nomination d'un administrateur
- Other28/10/2025STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
- Mandates31/07/2025DEMISSIONS, NOMINATIONS
- Mandates07/01/2025DEMISSIONS, NOMINATIONS
- Mandates18/03/2021DEMISSIONS, NOMINATIONS
- Mandates24/12/2019DEMISSIONS, NOMINATIONS
- Mandates20/12/2016DEMISSIONS, NOMINATIONS
- Mandates01/10/2013DEMISSIONS, NOMINATIONS
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsRegistered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Boulevard de France 9 bte A, 1420 Braine-l'AlleudCurrent | accounts 2021 → 2025 | Accounts 2025 · 2026-00145214 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| AXONE PHARMACurrent | accounts 2021 → 2025 | Accounts 2025 · 2026-00145214 |
Events
- 2025Annual accounts 20251,6 M €↑
- 2024Annual accounts 2024695,9 k €↑
- 2023Annual accounts 2023557,2 k €↓
- 2022Annual accounts 2022682,2 k €↓
- 2021Annual accounts 20212,5 M €↓
- 2020Annual accounts 20202,5 M €↑
- 2017Annual accounts 20171,1 M €↑
- 2016Annual accounts 2016755,6 k €↓
- 2014Annual accounts 2014897,2 k €↑
- 2013Annual accounts 201377,5 k €↑
- 2012Annual accounts 201234,1 k €↑
- 2011Annual accounts 2011-186,1 k €
- 22/10/2010IncorporationPublic limited company